Skip to main content
# Title Department Research Member Research Year
181 Expression of programmed death ligand-1 (PDL-1) in Acute Myeloid Leukemia Patients and its relation to post induction Department of Clinical Pathology Lamyaa Ahmed Abdelhafeez Ahmed 2021
182 Bendamustine in Refractory / Relapsed Non Hodgkin Lymphoma Department of Medical Oncology Dr. Maged Abdelfatah Amine Hassan 2021
183 Prognostic value of CD10, BCL6 and MUM1 in diffuse large B-cell lymphoma Department of Pathology Saly Salah Abdelhakeem 2021
184 Association of robust radiomic features from staging18F-FDG PET/CT in lung cancer with EGFR over expression and overall survival Department of Radiotherapy and Nuclear medicine Dr. Yasser Gaber Ali Abdelhafez 2021
185 Are Doppler Ultrasound Parameters Correlated with Thyroid Antibody Levels in Hypothyroid Patients with Hashimoto’s Thyroiditis Department of Radiology Dr. Omar Mustafa Mahmoud Mohamed 2021
186 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2021
187 Concurrent capecitabine with external beam radiotherapy versus radiotherapy alone in painful bone metastasis of breast cancer origin Department of Radiotherapy and Nuclear medicine Dr. Ayat allah Ali yousseif 2021
188 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Department of Clinical Pathology Dr. Mohamed Galal Mostafa ELnaggar 2021
189 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Department of Medical Oncology Dr. Ahmed Mubarak Hefni Ismail 2021
190 Role of serum miR-21 and miR-92a in colorectal cancer diagnosis as novel molecular biomarkers Department of Surgical Oncology Dr. Murad Aly Jabir Ahmed 2021